If you would have made an effort to read the top post, and understand the thread, you would have understood that my comment was in support of the investment, you half-witted birdbrain. LOL
It's hospital MARKETING, not a clinical trial conclusion! There are a number of medical practice websites you can access that say the same thing. The medical community doesn't care about advertising bias.
ISR has best isotope for multiple cancer application... Nope, and you have no reference for that.
FDA and CEO mark approvals... So what? Look at the revenue history. Hasn't helped.
Zero debt and a lot of cash... How else can they afford those salaries?
Recent insider buys... Nothing new.
New sales head from Bard... Yep.
New team overall... Not really.
Abstracts prove efficacy of cesium 131... No one is arguing its efficacy. We're arguing superiority.
News on lung, breast and brain applications... No breast studies. Lung was just released. Brain?
Large short position... not so large.
Certainly not to some medical group marketing blurb on a hospital website designed to pull in patients. You'll have to do better than that. There aren't any large scale long-term randomized trials that conclude Cs-131 is superior or a new standard of care in cancer therapy.
Not according to what I'm seeing which indicates T1 is around 10%. Type 2 diabetes represents about 90 to 95 percent of all diabetes cases. As many as three million Americans have type 1 diabetes, according to the Juvenile Diabetes Research Foundation (JDRF).
Countries with the most adults living with diabetes in 2013*
China 98.4 million
India 65.1 million
US 24.4 million
Brazil 11.9 million
Russian 10.9 million
Mexico 8.7 million
Indonesia 8.5 million
Germany 7.6 million
Egypt 7.5 million
Japan 7.2 million
*Source: International Diabetes Federation (IDF)
Ybor, I think I'll let you ramble on from here with no further criticism. Same goes for Jimmy and uww. At least you have some heart in it. The other two are ice cubes and have about the same IQ level. GL boys.
Will you straighten up for Krise sake? From one side of your mouth you say you can't expect the judge to make a decision just because you want it, and from the other side of your mouth you say the stock is worth $20 just BECAUSE YOU WANT it. That's called duplicity. Get some character.
It's hospital marketing and it's years old, advertising more than a half dozen therapies that the group offers. This is a good example of my comment about amateur investors. If you want to understand what you own, study the actual research.
Key words are "statistically insignificant.," along with "more clinical trials are necessary." Nothing has been proven that Cesium is superior to other isotopes in controlling cancer, or it would be stated by the research. None of the research has reached that conclusion in spite of what some here want you to think.
There is no one on this board – who is not a radiation oncologist – who is qualified to say that brachytherapy, much less Cs-131, is or should be the gold standard, standard of care, or cure for cancer, or that a patient has the capacity to choose his own course of treatment. That’s message board nonsense by amateur investors who are playing on Wall Street and looking to exploit other amateurs to make a buck.
That's embarrassing. Embarrassing for you, not your imaginary call center liars. You've never made a single comment here in reference to the science or the research, except to say that it's proven that Cesium is superior, when it hasn't. You're becoming desperate to bail out. It's more obvious with every post.
The book was published a decade ago and didn't make the bestsellers list. They're trying to do some editing now to publish a second edition, but the audience changed. Better late than never, I suppose. The 2.4 billion dollar market is not reality, it's hype to attract investors like you and uww and thourough.
You're an idiot, uww. And the truth? I doubt you'd know it if it fell on you like a sack of sh*#. You have no idea who a I am.
Coming from you that comment is hilarious. You don't have a clue about the science or the market, and you don't care. Keep pumping, moron.